85
Views
2
CrossRef citations to date
0
Altmetric
Expert Opinion

It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis

ORCID Icon, , , ORCID Icon, ORCID Icon, , , ORCID Icon, & show all
Pages 1479-1482 | Published online: 23 Dec 2019

References

  • Pereira D, Peleteiro B, Araujo J, et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage. 2011;19:1270–1285. doi:10.1016/j.joca.2011.08.00921907813
  • Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013;21(9):1145–1153. doi:10.1016/j.joca.2013.03.01823973124
  • Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115–2126. doi:10.1016/S0140-6736(11)60243-221684382
  • Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133:635–646. doi:10.7326/0003-4819-133-8-200010170-0001611033593
  • Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646–656.14710506
  • Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3–15. doi:10.1136/annrheumdis-2015-20752425969430
  • Ghouri A, Conaghan PG. Update on novel pharmacological therapies for osteoarthritis. Ther Adv Musculoskelet Dis. 2019;11:1–11.
  • Fernandes L, Hagen KB, Bijlsma JW, et al. European League Against Rheumatism (EULAR) EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis. 2013;72(7):1125–1135. doi:10.1136/annrheumdis-2012-20274523595142
  • McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363–388. doi:10.1016/j.joca.2014.01.00324462672
  • Meneses SR, Goode AP, Nelson AE, et al. Clinical algorithms to aid osteoarthritis guideline dissemination. Osteoarthritis Cartilage. 2016;24(9):1487–1499. doi:10.1016/j.joca.2016.04.00427095418
  • Bruyère O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253–263. doi:10.1016/j.semarthrit.2014.05.01424953861
  • Watt FE. Osteoarthritis biomarkers: year in review. Osteoarthritis Cartilage. 2018;26(3):312–318. doi:10.1016/j.joca.2017.10.01629107060
  • Castaneda S, Roman-Blas JA, Largo R, Herrero-Beaumont G. Osteoarthritis: a progressive disease with changing pheno- types. Rheumatology. 2014;53(1):1e3. doi:10.1093/rheumatology/ket24723878311
  • van der Esch M, Knoop J, van der Leeden M, et al. Clinical phenotypes in patients with knee osteoarthritis: a study in the Amsterdam osteoarthritis cohort. Osteoarthritis Cartilage. 2015;23(4):544–549. doi:10.1016/j.joca.2015.01.00625596322
  • Bruyère O, Cooper C, Arden N, et al. Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis. Drugs Aging. 2015;32(3):179–187. doi:10.1007/s40266-015-0243-325701074
  • Tubach F, Ravaud P, Martin-Mola E, et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res (Hoboken). 2012;64(11):1699–1707. doi:10.1002/acr.2174722674853
  • Migliore A, Scirè CA, Carmona L, et al. The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the italian society for rheumatology. Rheumatol Int. 2017;37(8):1227–1236. doi:10.1007/s00296-017-3700-y28451793